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R936Microsoft founder, Bill Gates, pledged 
more than $160 million from his 
charitable foundation to help develop 
vaccines for malaria as part of a 
package of funds totalling $3 billion 
revealed at a meeting at the UN to 
assess progress in the Millennium 
Development Goals to halve global 
poverty by 2015.
Gates said that his funds would 
be for the PATH Malaria Vaccine 
Initiative (MVI), in conjunction with 
the pharmaceutical company, 
GlaxoSmithKline. The plan is to 
support ‘next generation’ vaccines to 
find longer-lasting protection against 
the parasite.
“I’m very hopeful that the malaria 
vaccine currently in advanced testing 
will be proven effective, but that will 
just be the first step,” said Gates. 
“Now is the time to develop a new 
generation of vaccines that are even 
more effective and could someday 
help eradicate malaria altogether.”
Christian Loucq, director of the MVI, 
said the current vaccine, known as 
RTS,S, could be available by 2013 if 
it is swiftly approved by the European 
licensing authority and then the WHO, 
as seems likely. But the money from 
the Gates Foundation is aimed at 
accelerating development of an even 
better vaccine.
The MVI has entered into a number 
of collaborative agreements in the 
past few months in an effort to boost 
development. It is now working with 
the Walter and Eliza Hall Institute in 
Melbourne in an effort to isolate and 
evaluate particular antigens from 
the parasite that could be used in a 
vaccine. The MVI is also working with 
the Infectious Diseases Research 
Institute to develop new adjuvants for 
future vaccines and with the Seattle 
Biomedical Research Institute to help 
develop a ‘human challenge center’ 
devoted exclusively to testing the 
safety and efficacy of malaria vaccines.
“These new funds are recognition 
that we have a solid strategy in place 
to accelerate further malaria vaccine 
development — and the team to 
deliver on it,” said Loucq.
Attempts to eradicate malaria within 
the next decade got a $3 billion 
package of new funds revealed at a 
meeting at the UN last month.  
Nigel Williams reports.
Malaria battle boost The World Bank said it would increase spending on fighting malaria 
in Africa by $1.1 billion, and focus on 
the Democratic Republic of Congo 
and Nigeria, which account for 30–40 
per cent of malaria deaths worldwide. 
The bank’s president, Robert Zoelick, 
said some African countries had 
made progress in cutting malaria 
deaths through the distribution  
of bednets and more access to  
low-cost, effective drugs for treating 
the disease.
The Geneva-based Global Fund 
to fight AIDS, Tuberculosis and 
Malaria also said at the meeting 
that it would give grants totalling 
$1.62 billion over the next two years 
for work on malaria. Britain’s prime 
minister, Gordon Brown, attending 
the meeting, pledged $40 million and the Texas- based Marathon Oil 
pledged $28 million for Equatorial 
Guinea over five years. The UN high 
commissioner for refugees said he 
would give $2 million for insecticide-
treated bednets for refugees in 
Africa.
The announcements followed 
publication last month of the World 
Malaria Report 2008, by the World 
Health Organisation, which drew 
on data collected between 2004 
and 2006. “With dramatic increases 
in funding and intense momentum  
towards reducing the malaria burden 
in recent years, we have a greater 
need for reliable information and 
analysis,” said the WHO’s director-
general, Margaret Chan. “This report 
begins to answer that need. Progress 
in malaria control has accelerated Support: Bill Gates, through his charitable foundation, pledged funds in support of the World 




Nearly two centuries ago, Wilhelm 
von Humboldt (1767–1835) wrote 
a memorandum for the creation 
of a new university in Berlin. He 
emphasized three key principles, 
which came to be regarded as 
defining characteristics of the modern 
European universities, namely: 
unity of research and teaching, 
freedom of teaching, and academic 
self- governance. Humboldt very much 
regarded the production of highly 
educated people as an end in itself, 
and helped to revive the humanist 
tradition.
Today, however, political and 
economic pressures are increasingly 
squeezing Humboldt’s idealism out 
of university life, to replace it with 
a market-driven approach, where 
the university is seen as a factory 
that produces commodities (that is, 
a trained workforce) according to 
demand. Examples of this approach 
can be seen in the university reforms 
in many countries, and across Europe 
in the Bologna process designed to 
streamline university education and 
make it more efficient in producing the 
recruits employers want. 
Now the League of European 
Research Universities (LERU), a group 
of 20 leading universities across 
Europe, including Oxford, Cambridge, 
Zurich, Munich, and Paris 6, has 
issued a position paper, authored by 
Geoffrey Boulton (vice-principal at 
Edinburgh) and Colin Lucas (former 
vice-chancellor at Oxford), to defend 
the traditional independence of 
universities against such short-sighted 
market demands. “There is a growing 
tendency to see universities as 
sources of highly specific, marketable 
commodities,” the paper claims.
What the authors would like 
to see, by contrast, is “a better 
understanding of the broader function 
of universities,” which, they say, is in 
creating valuable benefits for society 
not in a direct, predictable way, but on 
complex, meandering pathways that 
cannot be forced into schedules and 
targets. 
Specifically, the paper attacks the 
European Commission for setting 
up its own university, the European 
Institute of Innovation and Technology 
(EIT), which was officially launched 
on September 15th, although with 
only a sixth of the budget of two 
billion euros originally envisioned. The 
European Commission defines the 
role of universities with the metaphor 
of a knowledge triangle consisting of 
education, research, and innovation 
(see Curr. Biol. 16, R229). 
The definition of utility is often 
too narrowly drawn
The LERU paper contends that 
innovation is only a desirable  
by-product of the deeper university 
culture based on creativity, freedom, 
and serendipity, and thus cannot be 
generated by force or management. 
Boulton and Lucas are not calling for 
the erection of ivory towers, and they 
acknowledge the role universities play 
in the creation of “useful knowledge”. 
However, they fear that “the definition 
of utility is often too narrowly drawn”.
The authors acknowledge the 
need for reforms, but fear that the 
increasingly forceful attempts to turn 
universities into entities that can be 
managed to meet output targets 
will destroy their current value for 
society. “Many of the qualities that 
governments prize in universities are 
by-products of deeper functions of 
the university. If those functions are 
undermined, the rest will also fail,”  
the paper warns. 
Boulton and Lucas also warn 
against the managerial fallacy, that is, 
the temptation to remove things that 
make management difficult. An easily 
governed university, they say, is no 
university at all. 
Will universities with the freedom 
that Humboldt envisioned survive 
beyond the approaching second 
centenary of his ideas? It will take 
more than just a position paper to 
stop the current trends. Widespread 
revolt, as practised in France in recent 
years, and for very similar reasons 
(see Curr. Biol. 14, R1031), may be the 
only option that can save Humboldt’s 
vision. 
Link: http://www.leru.org/
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A group of key universities is 
challenging market-driven targets. 
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Humboldt hopesdramatically since 2006, especially in the wake of the UN secretary-
general’s call for universal malaria 
control coverage by the end of 2010.”
The report reveals that new 
methods of estimating malaria 
incidence found 247 million cases of 
the disease in 2006. However, malaria 
deaths have declined in several 
countries and, in a few African 
nations, deaths have been reduced 
by half by the implementation of 
recommended measures. But in 
Africa one measure is still largely 
unavailable. The WHO-recommended 
artemisin-based combination therapy 
reached only 3 per cent of children in 
need, the report found.
But it found that recent increases 
in malaria funding were beginning to 
translate into coverage of key malaria 
interventions, especially bednets, 
by 2006. The percentage of children 
protected by insecticide-treated nets 
increased almost eightfold, from  
3 per cent in 2001 to 23 per cent 
in the 18 African countries where 
surveys were carried out in 2006. 
By the same year, about 100 million 
people, including 22 million in Africa, 
were protected by indoor spraying  
of insecticide.
“For the first time, three African 
countries reported dramatic 
reductions in malaria deaths by  
50 per cent or more. Eritrea, Rwanda 
and Sao Tome and Principe achieved 
this result between 2000 and 
2006–2007, the report says, through 
a mix of bednet distribution, indoor 
insecticide spraying, improved 
access to treatment and advances 
in disease surveillance. Significant 
improvements were also found in 
Madagascar, Zambia and Tanzania.
The improvements in Africa reflect 
increased funding — the continent 
had a larger increase from external 
donors than any other region 
between 2004 and 2006.
But there are still concerns about 
the pattern of funding for malaria. 
Researchers at the Kenya Medical 
Research Institute in Nairobi reported 
last month that spending varies 
widely between countries. They 
found the spending per person at risk 
was as low as one cent in Burma, but 
as high as $147 in Surinam in South 
America.
But the new funds, with a 
particular focus on Africa, should 
push countries in that continent up 
the league.
